Buscar resultados de ensayos clínicos

Patrocinado por

All - 128,731 Studies Found

Estado Estudiar
Not yet recruiting Nombre del estudio: Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition
Condición: Iatrogenic Cushing's Disease
Fecha: 2017-03-17
Intervenciones:
  • Drug: AZD4017 and prednisolone

Completed Nombre del estudio: Cognition, Steroids, and Imaging in Cushings Disease
Condición: Cushing Syndrome
Fecha: 2004-04-08
Completed Nombre del estudio: Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor
Condición:
  • Cushing's Disease
  • Corticotroph Adenoma Fecha: 2009-04-27
    Intervenciones: Drug: Cabergoline Dose 1 mg/week in divided doses, increased by 1 mg/week every month, to the maximum of
Completed Nombre del estudio: A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease
Condición: Cushing's Syndrome
Fecha: 2004-07-30
Intervenciones: Drug: SOM230 s.c.
Completed Nombre del estudio: Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
Condición:
  • Pituitary Neoplasms
  • Prolactinoma
  • ACT
    Fecha: 2013-01-22
    Intervenciones: Other: Educational Intervention A brochure and access to a website including videos that contain detaile
Completed Nombre del estudio: Effects of Hormone Stimulation on Brain Scans for Cushing s Disease
Condición: Pituitary Neoplasm
Fecha: 2011-10-21
Intervenciones: Drug: Acthrel Ovine Corticorelin
Active, not recruiting Nombre del estudio: Rhinological Outcomes in Endonasal Pituitary Surgery
Condición:
  • Pituitary Neoplasm
  • Pituitary Adenoma
  • Prolactinoma
    • Fecha: 2012-01-03
Completed Nombre del estudio: Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Condición:
  • Cushing's Disease
  • Acromegaly

  • Fecha: 2013-02-15
    Intervenciones: Drug: Pasireotide Pasireotide subcutaneous or Long Acting Release
Completed Nombre del estudio: Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors
Condición:
  • Pituitary Tumor
  • ACTH-producing Pituitary Tumour

Fecha: 2016-04-20
Intervenciones: Drug: Pasireotide LAR Pasireotide LAR (SIGNIFOR® LAR)
Terminated Nombre del estudio: Pasireotide Therapy in Patients With Nelson's Syndrome
Condición: Nelson Syndrome
Fecha: 2012-06-08
Intervenciones: Drug: Pasireotide 4 Weeks pasireotide 0.6mg s/c injections twice daily followed by 24 weeks treatment wi
<<< Previous | Next >>>